FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092541726> ?p ?o ?g. }

• W2092541726 endingPage "636" @default.
• W2092541726 startingPage "630" @default.
• W2092541726 abstract "We describe five patients with treated low-grade B-cell neoplasms who subsequently developed Epstein-Barr virus (EBV)-positive B-cell lymphoproliferative disorders (BLPDs). The low-grade B-cell neoplasms were B-cell chronic lymphocytic leukemia in four patients and splenic marginal zone lymphoma in one patient. All patients had received treatment with fludarabine for the low-grade B-cell neoplasm, and three had also received Campath-1H. The EBV-BLPDs arose 2-12 months after completion of fludarabine therapy and morphologically resembled the EBV-BLPDs that occur in the setting of iatrogenic immunodeficiency. Molecular genetic studies showed that these lesions were clonally distinct from the low-grade B-cell neoplasm in three of four cases assessed. Two patients did not receive therapy for the EBV-BLPD. The lesions regressed spontaneously in both patients but recurred in one. One patient underwent surgical excision and remains without evidence of the EBV-BLPD. One patient received aggressive multiagent chemotherapy with a complete response initially, but the EBV-BLPD recurred after 12 months. One patient received antiviral therapy and responded completely but died 2 months later of an opportunistic infection. We conclude that patients with low-grade B-cell neoplasms treated with fludarabine, possibly in combination with other immune suppressive agents, may subsequently develop EBV-BLPDs that morphologically resemble other iatrogenic immunodeficiency-associated BLPDs. Most are clonally distinct from the underlying low-grade B-cell neoplasm. A subset of these lesions may regress without systemic therapy." @default.
• W2092541726 created "2016-06-24" @default.
• W2092541726 creator A5027575595 @default.
• W2092541726 creator A5032901567 @default.
• W2092541726 creator A5035410664 @default.
• W2092541726 creator A5048796830 @default.
• W2092541726 creator A5051740273 @default.
• W2092541726 creator A5059138314 @default.
• W2092541726 creator A5070451207 @default.
• W2092541726 creator A5073079562 @default.
• W2092541726 date "2002-05-01" @default.
• W2092541726 modified "2023-10-11" @default.
• W2092541726 title "Epstein–Barr Virus-Positive B-Cell Lymphoproliferative Disorders Arising in Immunodeficient Patients Previously Treated With Fludarabine for Low-Grade B-Cell Neoplasms" @default.
• W2092541726 cites W1894099448 @default.
• W2092541726 cites W2015120596 @default.
• W2092541726 cites W2018847258 @default.
• W2092541726 cites W2019796780 @default.
• W2092541726 cites W2041643918 @default.
• W2092541726 cites W2051828495 @default.
• W2092541726 cites W2053225831 @default.
• W2092541726 cites W2056641426 @default.
• W2092541726 cites W2060849826 @default.
• W2092541726 cites W2081332505 @default.
• W2092541726 cites W2151861992 @default.
• W2092541726 cites W2164735313 @default.
• W2092541726 cites W2166939118 @default.
• W2092541726 cites W2221772045 @default.
• W2092541726 cites W2329403993 @default.
• W2092541726 cites W4244246706 @default.
• W2092541726 cites W4319292969 @default.
• W2092541726 cites W88096824 @default.
• W2092541726 doi "https://doi.org/10.1097/00000478-200205000-00009" @default.
• W2092541726 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11979093" @default.
• W2092541726 hasPublicationYear "2002" @default.
• W2092541726 type Work @default.
• W2092541726 sameAs 2092541726 @default.
• W2092541726 citedByCount "80" @default.
• W2092541726 countsByYear W20925417262012 @default.
• W2092541726 countsByYear W20925417262013 @default.
• W2092541726 countsByYear W20925417262014 @default.
• W2092541726 countsByYear W20925417262015 @default.
• W2092541726 countsByYear W20925417262016 @default.
• W2092541726 countsByYear W20925417262018 @default.
• W2092541726 countsByYear W20925417262019 @default.
• W2092541726 countsByYear W20925417262020 @default.
• W2092541726 countsByYear W20925417262021 @default.
• W2092541726 crossrefType "journal-article" @default.
• W2092541726 hasAuthorship W2092541726A5027575595 @default.
• W2092541726 hasAuthorship W2092541726A5032901567 @default.
• W2092541726 hasAuthorship W2092541726A5035410664 @default.
• W2092541726 hasAuthorship W2092541726A5048796830 @default.
• W2092541726 hasAuthorship W2092541726A5051740273 @default.
• W2092541726 hasAuthorship W2092541726A5059138314 @default.
• W2092541726 hasAuthorship W2092541726A5070451207 @default.
• W2092541726 hasAuthorship W2092541726A5073079562 @default.
• W2092541726 hasConcept C126322002 @default.
• W2092541726 hasConcept C142724271 @default.
• W2092541726 hasConcept C159654299 @default.
• W2092541726 hasConcept C203014093 @default.
• W2092541726 hasConcept C2522874641 @default.
• W2092541726 hasConcept C2776694085 @default.
• W2092541726 hasConcept C2776755627 @default.
• W2092541726 hasConcept C2776995267 @default.
• W2092541726 hasConcept C2777938653 @default.
• W2092541726 hasConcept C2778453870 @default.
• W2092541726 hasConcept C2778461978 @default.
• W2092541726 hasConcept C2779263901 @default.
• W2092541726 hasConcept C2779338263 @default.
• W2092541726 hasConcept C2780635560 @default.
• W2092541726 hasConcept C2781375147 @default.
• W2092541726 hasConcept C71924100 @default.
• W2092541726 hasConceptScore W2092541726C126322002 @default.
• W2092541726 hasConceptScore W2092541726C142724271 @default.
• W2092541726 hasConceptScore W2092541726C159654299 @default.
• W2092541726 hasConceptScore W2092541726C203014093 @default.
• W2092541726 hasConceptScore W2092541726C2522874641 @default.
• W2092541726 hasConceptScore W2092541726C2776694085 @default.
• W2092541726 hasConceptScore W2092541726C2776755627 @default.
• W2092541726 hasConceptScore W2092541726C2776995267 @default.
• W2092541726 hasConceptScore W2092541726C2777938653 @default.
• W2092541726 hasConceptScore W2092541726C2778453870 @default.
• W2092541726 hasConceptScore W2092541726C2778461978 @default.
• W2092541726 hasConceptScore W2092541726C2779263901 @default.
• W2092541726 hasConceptScore W2092541726C2779338263 @default.
• W2092541726 hasConceptScore W2092541726C2780635560 @default.
• W2092541726 hasConceptScore W2092541726C2781375147 @default.
• W2092541726 hasConceptScore W2092541726C71924100 @default.
• W2092541726 hasIssue "5" @default.
• W2092541726 hasLocation W20925417261 @default.
• W2092541726 hasLocation W20925417262 @default.
• W2092541726 hasOpenAccess W2092541726 @default.
• W2092541726 hasPrimaryLocation W20925417261 @default.
• W2092541726 hasRelatedWork W1964100413 @default.
• W2092541726 hasRelatedWork W2023984538 @default.
• W2092541726 hasRelatedWork W2044556191 @default.
• W2092541726 hasRelatedWork W2098234787 @default.
• W2092541726 hasRelatedWork W2131897387 @default.
• W2092541726 hasRelatedWork W2165507228 @default.

• next